PATENT CLAIM ANALYSIS

Application Number: 15865378
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-12
Patent Classification: ["424", "009340"]

Abstract:
Provided are novel human α-synuclein-specific antibodies as well as fragments, derivatives and variants thereof as well as methods related thereto. Assays, kits, and solid supports related to antibodies specific for α-synuclein are also disclosed. The antibody, immunoglobulin chain(s), as well as binding fragments, derivatives and variants thereof can be used in pharmaceutical and diagnostic compositions for α-synuclein targeted immunotherapy and diagnosis, respectively.

Claim (Index 46):
The method of  claim 45 , wherein the human subject has or is suspected of having Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, Parkinson's disease dementia, or the Lewy body variant of Alzheimer's disease.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 86.0
- Lexical Diversity: 1.59574
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13140699', '15005948', '15410128', '14128497', '14654176']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8497337360055656
- 35 USC 102 Novelty (BERT): 0.6295361429873998
- Combined Prediction Score: 0.827713976703749
- Mean Citation Score: 618.1686000000002
- Max Citation Score: 696.7445
- Similarity Product: 520.0679514293671

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test